use [ftcn]    
Possibly [qlco]    
Associated [qlco]    
Lower [spco]    
Incidence [qnco]    
Hepatocellular carcinoma [neop]    
Hepatitis C virus [virs]    
Associated [qlco]    
Liver Cirrhosis [dsyn]    
Previous [tmco]    
studies [mnob]    
patient [podg]    
Hepatitis C virus [virs]    
Associated [qlco]    
Liver Cirrhosis [dsyn]    
Hepatitis C virus [virs]    
Show [inpr]    
Increase [qnco]    
Hepatic inflammation [fndg]    
Assess [acty]    
High [qlco]    
Serum [bdsu]    
Associated [qlco]    
Increase [qnco]    
Risk [qlco]    
development [phsf]    
Hepatocellular carcinoma [neop]    
This [euka]    
Suggest [idcn]    
suppress [patf]    
Inflammation [patf]    
Arrest [dsyn]    
Hepatocellular carcinoma [neop]    
development [phsf]    
Hepatitis C virus [virs]    
Several [qnco]    
Agent [chvf]    
Suggest [idcn]    
To [qlco]    
possess [mobd]    
Chemoprevention [qlco]    
Potential [qlco]    
development [phsf]    
Hepatocellular carcinoma [neop]    
Chronic liver disease [dsyn]    
Hepatitis C virus [virs]    
Associated [qlco]    
include [ftcn]    
Herbal Medicine [plnt]    
TJ-9 [phsu]    
used [fndg]    
To [qlco]    
TREAT [ftcn]    
Cholestatic liver disease [dsyn]    
possess [mobd]    
Anti-inflammatory [phsu]    
properties [qlco]    
Liver disease [dsyn]    
suppress [patf]    
Hepatic inflammation [fndg]    
Assess [acty]    
Decrease [qnco]    
serum ALT [lbpr]    
Arrest [dsyn]    
Hepatocellular carcinoma [neop]    
occurrence [ftcn]    
patient [podg]    
Hepatitis C virus [virs]    
studies [mnob]    
PREVENT [ftcn]    
Effect [qlco]    
Hepatocellular carcinoma [neop]    
examinations [fndg]    
patient [podg]    
Early Stage [clas]    
Hepatitis C virus [virs]    
One [qnco]    
Two [qnco]    
patient [podg]    
Hepatitis C virus [virs]    
Child [aggp]    
Stage [tmco]    
TREAT [topp]    
anti inflammatory drugs [phsu]    
Goal [inpr]    
Lower [spco]    
Average [qnco]    
serum ALT [lbpr]    
Level [qlco]    
IU [qnco]    
If [qlco]    
Average [qnco]    
Level [qlco]    
Not [ftcn]    
IU [qnco]    
treatment [ftcn]    
One [qnco]    
Agent [chvf]    
Therapies [ftcn]    
Initial [idcn]    
patient [podg]    
followed [tmco]    
>5 [qnco]    
year [tmco]    
Two [qnco]    
Group [idcn]    
User [humn]    
a group [clas]    
Group [idcn]    
Mean [qnco]    
SD [fndg]    
Dosage [qnco]    
Administer [ftcn]    
a group [clas]    
mg/d [qnco]    
Average [qnco]    
Duration [tmco]    
Administration [ocac]    
a group [clas]    
month [tmco]    
>5 [qnco]    
year [tmco]    
studies [mnob]    
period [tmco]    
Cumulative [qlco]    
Incidence [qnco]    
Hepatocellular carcinoma [neop]    
Record [inpr]    
>5 [qnco]    
year [tmco]    
Incidence [qnco]    
Hepatocellular carcinoma [neop]    
a group [clas]    
Lower [spco]    
Group [idcn]    
Risk [qlco]    
Hepatocellular carcinoma [neop]    
Incidence [qnco]    
Calculate [ftcn]    
Regressing [patf]    
Show [inpr]    
Administration [ocac]    
Decrease [qnco]    
Genesis [gngm]    
Herbal Medicine [plnt]    
used [fndg]    
Dosage [qnco]    
treatment duration [tmco]    
Non [ftcn]    
Group [idcn]    
Conclusion [idcn]    
PREVENT [phsu]    
Hepatocellular carcinoma [neop]    
development [phsf]    
Hepatitis C virus [virs]    
serum ALT [lbpr]    
trend [tmco]    
Time [tmco]    
Same [qlco]    
Group [idcn]    
Chemoprevention [qlco]    
Effect [qlco]    
Not [ftcn]    
greater [qnco]    
reduction [npop]    
Compare [acty]    
